Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance
Clinical trial NCT06633757 · COMPLETED
Trial details
- NCT number
- NCT06633757
- Sponsor
- ReCode Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-22
- Primary completion
- 2025-06-30
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.